| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2007 | 2007 | ||||||||
|
lymphotoxin alpha | 0.434 | 0.885 | 0.20 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 1990 | 1993 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2013 | 2013 | ||||||||
|
inhibitor of nuclear factor kappa B kinase subunit beta | 0.506 | 0.846 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2009 | 2010 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2010 | 2013 | ||||||||
|
C-X-C motif chemokine receptor 2 | 0.445 | 0.923 | 1.4E-02 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2005 | 2013 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 1990 | 1991 | ||||||||
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.488 | 0.769 | 0.74 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
CD40 ligand | 0.414 | 0.846 | 0.72 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
mucin 4, cell surface associated | 0.506 | 0.769 | 2.8E-54 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
proteasome 20S subunit beta 9 | 0.514 | 0.808 | 2.7E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
RELB proto-oncogene, NF-kB subunit | 0.597 | 0.731 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
solute carrier family 5 member 7 | 0.597 | 0.654 | 1.5E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
CD4 molecule | 0.604 | 0.654 | 7.9E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
hepatitis A virus cellular receptor 2 | 0.450 | 0.808 | 3.9E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
platelet derived growth factor D | 0.579 | 0.538 | 1.7E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
xanthine dehydrogenase | 0.529 | 0.846 | 2.6E-22 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
TNF receptor superfamily member 1B | 0.425 | 0.885 | 0.50 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
thromboxane A2 receptor | 0.597 | 0.654 | 1.3E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
Spi-1 proto-oncogene | 0.631 | 0.654 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 |